Stock Rating Upgrade
The Value Trend Rating for MediWound Ltd (NASDAQ: MDWD) improved in the last week from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
MediWound Ltd (NASDAQ: MDWD) stock closed at $15.99 on 4/12/24 after a modest gain of 0.9%. NORMAL trading volume accompanied the advance. The stock has risen 4.4% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, MDWD is expected to be Value Creation neutral.
MediWound has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. MediWound has a very low Appreciation Score of 5 but a very high Power Rating of 86, with the Low Neutral Value Trend Rating the result.
Be the first to comment